Revision as of 13:40, 10 January 2012 editBeetstra (talk | contribs)Edit filter managers, Administrators172,031 edits Saving copy of the {{chembox}} taken from revid 459240436 of page Tocopheryl_acetate for the Chem/Drugbox validation project (updated: ''). |
Latest revision as of 15:17, 19 November 2024 edit 71.255.141.126 (talk)No edit summary |
Line 1: |
Line 1: |
|
|
{{Short description|Vitamin}} |
|
{{ambox | text = This page contains a copy of the infobox ({{tl|chembox}}) taken from revid of page ] with values updated to verified values.}} |
|
|
|
{{cs1 config|name-list-style=vanc}} |
|
|
{{lowercasetitle}} |
|
|
{{Use mdy dates|date=February 2024}} |
|
{{chembox |
|
{{chembox |
|
|
| Name = α-Tocopheryl acetate |
|
| verifiedrevid = 419011964 |
|
| verifiedrevid = 470611314 |
|
| ImageFile1 = Tocopheryl acetate.png |
|
| ImageFile1 = Tocopheryl acetate.png |
|
|
| ImageAlt1 = RRR-α-Tocopheryl acetate |
|
| ImageSize1 = 200px |
|
|
| ImageFile2= Tocopheryl_acetate_3d_structure.png |
|
| ImageFile2= Tocopheryl_acetate_3d_structure.png |
|
|
| ImageAlt2 = RRR-α-Tocopheryl acetate |
|
| ImageSize2 = 200px |
|
|
| IUPACName = chroman-6-yl] acetate |
|
| PIN = (2''R'')-2,5,7,8-Tetramethyl-2--3,4-dihydro-2''H''-1-benzopyran-6-yl acetate |
|
| OtherNames = Tocopherol acetate <br>Vitamin E acetate |
|
| OtherNames = α-Tocopherol acetate<br>Vitamin E acetate |
|
| Section1 = {{Chembox Identifiers |
|
|Section1={{Chembox Identifiers |
|
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
|
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
|
| ChemSpiderID = 77987 |
|
| ChemSpiderID = 77987 |
|
| UNII_Ref = {{fdacite|correct|FDA}} |
|
| UNII_Ref = {{fdacite|correct|FDA}} |
Line 22: |
Line 26: |
|
| StdInChIKey = ZAKOWWREFLAJOT-CEFNRUSXSA-N |
|
| StdInChIKey = ZAKOWWREFLAJOT-CEFNRUSXSA-N |
|
| CASNo = 58-95-7 |
|
| CASNo = 58-95-7 |
|
|
| CASNo_Comment =RRR-α-isomer |
|
| CASNo_Ref = {{cascite|correct|CAS}} |
|
| CASNo_Ref = {{cascite|correct|CAS}} |
|
| PubChem = 86472 |
|
| PubChem = 86472 |
⚫ |
| SMILES = O=C(Oc2c(c(c1O(CCc1c2C)(C)CCC(C)CCC(C)CCCC(C)C)C)C)C |
|
|
|
| DrugBank = DB14003 |
|
⚫ |
| SMILES = O=C(Oc2c(c(c1O(CCc1c2C)(C)CCC(C)CCC(C)CCCC(C)C)C)C)C |
|
}} |
|
}} |
|
| Section2 = {{Chembox Properties |
|
|Section2={{Chembox Properties |
|
| Formula = C<sub>31</sub>H<sub>52</sub>O<sub>3</sub> |
|
| Formula = C<sub>31</sub>H<sub>52</sub>O<sub>3</sub> |
|
| MolarMass = 472.743 g/mol |
|
| MolarMass = 472.743 g/mol |
|
| Appearance = |
|
| Appearance =pale yellow, viscous liquid<ref name=m/> |
|
| Density = |
|
| Density = |
|
| MeltingPt = |
|
| MeltingPt =–27.5 °C |
|
|
| MeltingPt_ref =<ref name=m/> |
|
| BoilingPt = |
|
|
| Solubility = |
|
| BoilingPt =240 °C |
|
|
| BoilingPt_notes =decays without boiling<ref name=eu/> |
|
|
| Solubility =insoluble<ref name=m/> |
|
|
| SolubleOther =soluble in ], ], ]; poorly soluble in ]<ref name=m/> |
|
}} |
|
}} |
|
| Section3 = {{Chembox Hazards |
|
|Section3={{Chembox Hazards |
|
| MainHazards = |
|
| NFPA-H = 1 |
|
| FlashPt = |
|
| NFPA-F = 1 |
|
| Autoignition = |
|
| NFPA-R = 0 |
|
|
| MainHazards = |
|
|
| FlashPt = |
|
|
| AutoignitionPt = |
|
}} |
|
}} |
|
}} |
|
}} |
|
|
'''α-Tocopheryl acetate''' ('''''alpha''-tocopherol acetate'''), also known as '''vitamin E acetate''', is a form of ] with D-Alpha Tocopheryl Acetate as the natural form and DL-Alpha Tocopheryl Acetate as the synthetic form. DL-indicates the synthetic form where as D- indicates the natural form. It is the ] of ] and {{nowrap|]}}.<ref name=eu/> |
|
|
|
|
|
The ] says that vitamin E acetate is a very strong culprit of concern in the ] of ] (VAPI),<ref name=CDC----2019/> but there is not yet sufficient evidence to rule out contributions from other chemicals.<ref>{{cite journal|last1=Feldman|first1=Ryan|last2=Meiman|first2=Jonathan|last3=Stanton|first3=Matthew|last4=Gummin|first4=David D.|date=June 2020|title=Culprit or correlate? An application of the Bradford Hill criteria to Vitamin E acetate|journal=Archives of Toxicology|volume=94|issue=6|pages=2249–2254|doi=10.1007/s00204-020-02770-x|issn=1432-0738|pmid=32451600|s2cid=218878143}}</ref><ref name=CDC2019/> Vaporization of this ester produces toxic ] products.<ref name=pmid32156732/> |
|
|
|
|
|
==Use in cosmetics== |
|
|
α-Tocopheryl acetate is often used in ] ] such as skin creams. It is not oxidized and can penetrate through the skin to the living cells, where about 5% is converted to free ]. Claims are made for beneficial antioxidant effects.<ref>{{webarchive |url=https://web.archive.org/web/20150223105720/http://lpi.oregonstate.edu/fw04/allaboute.html|date=February 23, 2015|title=Linus Pauling Institute Research Report: All About E }}</ref> α-Tocopheryl acetate is used as an alternative to tocopherol itself because the ]ic ] is blocked, providing a less acidic product with a longer shelf life. It is believed that the acetate is slowly ] after it is absorbed into the skin, regenerating tocopherol and providing protection against the sun's ] rays.<ref>{{cite journal |vauthors=Beijersbergen van Henegouwen G, Junginger H, de Vries H |title=Hydrolysis of RRR-alpha-tocopheryl acetate (vitamin E acetate) in the skin and its UV protecting activity (an in vivo study with the rat) |journal=J Photochem Photobiol B |volume=29 |issue=1 |pages=45–51 |year=1995 |pmid=7472802 |doi=10.1016/1011-1344(95)90251-1}}</ref> Tocopheryl acetate was first synthesized in 1963 by workers at ].<ref name="MayerSchudel1963">{{cite journal|last1=Mayer|first1=H.|last2=Schudel|first2=P.|last3=Rüegg|first3=R.|last4=Isler|first4=O.|title=Über die Chemie des Vitamins E. 3. Mitteilung. Die Totalsynthese von (2''R'', 4''′R'', 8''′R'')- und (2''S'', 4''′R'', 8''′R'')-α-Tocopherol|journal=Helvetica Chimica Acta|volume=46|issue=2|year=1963|pages=650–671|issn=0018-019X|doi=10.1002/hlca.19630460225}}</ref> |
|
|
|
|
|
Although there is widespread use of tocopheryl acetate as a ], with claims for improved ] and reduced ] tissue,<ref>{{cite journal |vauthors=Panin G, Strumia R, Ursini F |title=Topical alpha-tocopherol acetate in the bulk phase: eight years of experience in skin treatment |journal=Ann. N. Y. Acad. Sci. |volume=1031 |pages=443–447 |date=2004 |issue=1 |pmid=15753192 |doi=10.1196/annals.1331.069 |bibcode=2004NYASA1031..443P |s2cid=45771699 |s2cid-access=free |url=https://images-na.ssl-images-amazon.com/images/I/B2tgqw5FeaS.pdf }}</ref> reviews have repeatedly concluded that there is insufficient evidence to support these claims.<ref>{{cite journal |vauthors=Sidgwick GP, McGeorge D, Bayat A |title=A comprehensive evidence-based review on the role of topicals and dressings in the management of skin scarring |journal=Arch. Dermatol. Res. |volume=307 |issue=6 |pages=461–477 |year=2015 |pmid=26044054 |pmc=4506744 |doi=10.1007/s00403-015-1572-0 |doi-access=free }}</ref><ref>{{cite journal |vauthors=Tanaydin V, Conings J, Malyar M, van der Hulst R, van der Lei B |title=The Role of Topical Vitamin E in Scar Management: A Systematic Review |journal=Aesthet Surg J |volume=36 |issue=8 |pages=959–965 |date=2016 |pmid=26977069 |doi=10.1093/asj/sjw046|doi-access=free }}</ref> There are reports of vitamin E-induced allergic contact dermatitis from use of vitamin E derivatives such as ] and tocopherol acetate in skin care products. Incidence is low despite widespread use.<ref>{{cite journal |vauthors=Kosari P, Alikhan A, Sockolov M, Feldman SR |title=Vitamin E and allergic contact dermatitis |journal=Dermatitis |volume=21 |issue=3 |pages=148–153 |date=2010 |pmid=20487657 |doi=10.2310/6620.2010.09083|s2cid=38212099 }}</ref> |
|
|
|
|
|
==Misuse== |
|
|
|
|
|
===Ingredient in vape liquids=== |
|
|
{{also|2019–20 vaping lung illness outbreak|Vaping-associated pulmonary injury|Lacing (drugs)#Cannabis}} |
|
|
|
|
|
On September 5, 2019, the United States ] (US FDA) announced that 10 out of 18, or 56% of the samples of vape liquids sent in by states, linked to ], tested positive for vitamin E acetate<ref>{{cite news|url=https://www.washingtonpost.com/health/2019/09/05/contaminant-found-vaping-products-linked-deadly-lung-illnesses-state-federal-labs-show/|title=Contaminant found in marijuana vaping products linked to deadly lung illnesses, tests show|last=Sun|first=Lena|date=September 6, 2019|newspaper=Washington Post|language=en|access-date=September 9, 2019}}</ref> which had been used as a thickening agent by ] THC vape cartridge manufacturers.<ref>{{cite magazine|url=https://www.rollingstone.com/culture/culture-features/vaping-honey-cut-mystery-thickener-vitamin-e-acetate-vapes-881896/|title=Three Companies Subpoenaed in Weed Vape Illness Investigation|date=September 10, 2019|magazine=Rolling Stone|language=en}}</ref> On November 8, 2019, the ] (CDC) identified vitamin E acetate as a very strong culprit of concern in the vaping-related illnesses, but has not ruled out other chemicals or toxicants as possible causes.<ref name=CDC----2019/> The CDC's findings were based on fluid samples from the lungs of 29 patients with ], which provided direct evidence of vitamin E acetate at the primary site of injury in all the 29 lung fluid samples tested.<ref name=CDC----2019>{{cite web|url=https://www.cdc.gov/media/releases/2019/t1108-telebriefing-vaping.html|title=Transcript of CDC Telebriefing: Update on Lung Injury Associated with E-cigarette Use, or Vaping|publisher=Centers for Disease Control and Prevention|date=November 8, 2019}}{{PD-notice}}</ref> Research suggests when vitamin E acetate is inhaled, it may interfere with normal lung functioning.<ref name=CDC2019>{{cite web|url=https://www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-disease.html|title=Outbreak of Lung Injury Associated with E-Cigarette Use, or Vaping|publisher=]|date=November 8, 2019}}{{PD-notice}}</ref> A 2020 study found that vaporizing vitamin E acetate produced carcinogenic ] and ], but also exceptionally toxic ] gas, which may be a contributing factor to the pulmonary injuries.<ref name=pmid32156732>{{cite journal|last1=Wu|first1=D|last2=O'Shea|first2=DF|date=March 24, 2020|title=Potential for release of pulmonary toxic ketene from vaping pyrolysis of vitamin E acetate|journal=Proceedings of the National Academy of Sciences of the United States of America|volume=117|issue=12|pages=6349–6355|doi=10.1073/pnas.1920925117|pmc=7104367|pmid=32156732|doi-access=free|bibcode=2020PNAS..117.6349W}}</ref> |
|
|
|
|
|
==Chemistry== |
|
|
At room temperature, α-tocopheryl acetate is a fat-soluble liquid. It has 3 ] and thus 8 ]. It is made by ]ifying ] with ]. 2''R'',4''R'',8''R''-isomer, also known as RRR-α-tocopheryl acetate, is the most common isomer used for various purposes. This is because α-tocopherol occurs in nature primarily as RRR-α-tocopherol.<ref name=eu>{{cite journal|date=2016|title=Safety assessment of the substance α-tocopherol acetate for use in food contact materials|journal=EFSA Journal|volume=14|issue=3|pages=4412|doi=10.2903/j.efsa.2016.4412|doi-access=free}}</ref> |
|
|
|
|
|
α-Tocopherol acetate does not boil at ] and begins to degrade at 240 °C.<ref name=eu/> It can be ]: it boils at 184 °C at 0.01 ], at 194 °C (0.025 mmHg) and at 224 °C (0.3 mmHg). In practice, it is not degraded notably by ], ] or ]. It has a ] of 1.4950–1.4972 at 20 °C.<ref name=m>{{cite book|title=The Merck index|date=1996|publisher=Merck|isbn=9780911910124|edition=12th|pages=1580|display-authors=et al}}</ref> |
|
|
|
|
|
α-Tocopherol acetate is ] to α-tocopherol and acetic acid under suitable conditions or when ingested by people.<ref name=eu/> |
|
|
|
|
|
== References == |
|
|
{{Reflist}} |
|
|
|
|
|
] |
|
|
] |
|
|
] |